HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint.

AuthorsDag Nyholm, Håkan Askmark, Sten-Magnus Aquilonius
JournalAnnals of neurology (Ann Neurol) Vol. 69 Issue 2 Pg. 424; author reply 425 (Feb 2011) ISSN: 1531-8249 [Electronic] United States
PMID21387388 (Publication Type: Comment, Letter)
Chemical References
  • Antiparkinson Agents
  • Catechols
  • Nitriles
  • Levodopa
  • entacapone
Topics
  • Antiparkinson Agents (adverse effects, pharmacokinetics)
  • Catechols (adverse effects, pharmacokinetics)
  • Dyskinesia, Drug-Induced
  • Humans
  • Levodopa (adverse effects, pharmacokinetics)
  • Nitriles (adverse effects, pharmacokinetics)
  • Parkinson Disease (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: